Treatment of psoriasis with crisaborole

Erica B. Lee, Mark G. Lebwohl, Jashin J. Wu

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Abstract

Crisaborole, a topical phosphodiesterase-4 (PDE4) inhibitor, is effective in patients with atopic dermatitis. As systemic PDE4 inhibition has also been used with success in psoriasis, clinical trials are underway to determine the utility of topical PDE4 inhibitors in these patients. However, there is no current literature documenting use of crisaborole for psoriasis. Here, we present two cases in which patients with psoriasis were treated successfully with crisaborole.

Original languageEnglish
Pages (from-to)156-157
Number of pages2
JournalJournal of Dermatological Treatment
Volume30
Issue number2
DOIs
StatePublished - 17 Feb 2019

Keywords

  • Psoriasis
  • crisaborole
  • phosphodiesterase-4

Fingerprint

Dive into the research topics of 'Treatment of psoriasis with crisaborole'. Together they form a unique fingerprint.

Cite this